Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyperthermia in oncology.
Falk MH, Issels RD. Falk MH, et al. Int J Hyperthermia. 2001 Jan-Feb;17(1):1-18. doi: 10.1080/02656730150201552. Int J Hyperthermia. 2001. PMID: 11212876 Review.
Heart transplantation: an approach to treating primary cardiac sarcoma?
Uberfuhr P, Meiser B, Fuchs A, Schulze C, Reichenspurner H, Falk M, Weiss M, Wintersperger B, Issels R, Reichart B. Uberfuhr P, et al. J Heart Lung Transplant. 2002 Oct;21(10):1135-9. doi: 10.1016/s1053-2498(02)00409-6. J Heart Lung Transplant. 2002. PMID: 12398881
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Schlemmer M, Wendtner CM, Falk M, Abdel-Rahman S, Licht T, Baumert J, Straka C, Hentrich M, Salat C, Hiddemann W, Issels RD. Schlemmer M, et al. Oncology. 2006;71(1-2):32-9. doi: 10.1159/000100447. Epub 2007 Mar 5. Oncology. 2006. PMID: 17344669 Clinical Trial.
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Wendtner C, Abdel-Rahman S, Baumert J, Falk MH, Krych M, Santl M, Hiddemann W, Issels RD. Wendtner C, et al. Among authors: falk mh. Eur J Cancer. 2001 Sep;37(13):1609-16. doi: 10.1016/s0959-8049(01)00191-5. Eur J Cancer. 2001. PMID: 11527685 Clinical Trial.
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Issels RD, Abdel-Rahman S, Wendtner C, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W. Issels RD, et al. Among authors: falk mh. Eur J Cancer. 2001 Sep;37(13):1599-608. doi: 10.1016/s0959-8049(01)00183-6. Eur J Cancer. 2001. PMID: 11527684 Clinical Trial.
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group.
Thaler J, Gastl G, Fluckinger T, Niederwieser D, Huber H, Seewann H, Sill H, Lang A, Falk M, Duba C, Utermann G, Kühr T, Aulitzky W, Huber C. Thaler J, et al. Ann Hematol. 1996 Jun;72(6):349-55. doi: 10.1007/s002770050185. Ann Hematol. 1996. PMID: 8767103 Clinical Trial.
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial.
Butts C, Maksymiuk A, Goss G, Soulières D, Marshall E, Cormier Y, Ellis PM, Price A, Sawhney R, Beier F, Falk M, Murray N. Butts C, et al. J Cancer Res Clin Oncol. 2011 Sep;137(9):1337-42. doi: 10.1007/s00432-011-1003-3. Epub 2011 Jul 9. J Cancer Res Clin Oncol. 2011. PMID: 21744082 Clinical Trial.
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page